Sawyer & Company, Inc Novartis Ag Transaction History

Sawyer & Company, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$92.52 - $104.91 $5,551 - $6,294	-60 Reduced 41.38%	85 $9,000
Q3 2022 Oct 25, 2022	SELL	$74.61 - $87.26 $1,865 - $2,181	-25 Reduced 14.71%	145 $11,000
Q2 2022 Jul 20, 2022	SELL	$80.52 - $93.75 $2,415 - $2,812	-30 Reduced 15.0%	170 $14,000
Q1 2022 Apr 26, 2022	BUY	$80.11 - $90.62 $16,022 - $18,124	200 New	200 $18,000
Q4 2021 Jan 14, 2022	SELL	$79.7 - $88.13 $18,570 - $20,534	-233 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$82.14 - $91.0 $80,497 - $89,180	-980 Reduced 80.79%	233 $20,000
Q2 2020 Jul 31, 2020	SELL	$80.93 - $91.1 $59,888 - $67,414	-740 Reduced 37.89%	1,213 $106,000
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $10,600 - $14,851	-150 Reduced 7.13%	1,953 $161,000
Q2 2019 Jul 23, 2019	SELL	$75.4 - $92.8 $20,735 - $25,520	-275 Reduced 11.56%	2,103 $192,000
Q1 2018 Apr 17, 2018	BUY	$70.39 - $84.15 $14,078 - $16,830	200 Added 9.18%	2,378 $192,000
Q4 2017 Jan 11, 2018	BUY	$72.33 - $77.64 $157,534 - $169,099	2,178	2,178 $183,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Sawyer & Company, Inc with notifications on news.